IFS Advisors’s CVS Health CVS Stock Holding History

IFS Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100	Closed	-$6K	–	50
2020 Q4	$6K	Buy	+100	New	+$6.5K	﹤0.01%	119

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IFS Advisors's CVS Position: Q1 2021 in Review

IFS Advisors sold out of CVS Health (CVS) in Q1 2021, closing a stake of 100 shares — an estimated $6K sold.

IFS Advisors first reported a position in CVS in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

IFS Advisors reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
IFS Advisors sold 100 CVS Health shares in Q1 2021, an estimated $6K.
IFS Advisors first reported a position in CVS Health in Q4 2020 and held it in 1 quarter.
IFS Advisors's CVS Health position peaked at $6K in Q4 2020.
2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on IFS Advisors's 13F filing for Q1 2021, filed 28 Apr 2021.